Treatment of Older AML in 2021 - April 1
Review the treatment options and recently approved therapies for older patients with AML
Medical Oncologists throughout the UPMC Hillman Cancer Center Network
- Describe the recently approved therapies for older patients with AML who are not fit for induction chemotherapy
- Identify challenges in management and review recommendations to address these obstacles
Treatment of Older AML in 2021
Thursday, April 1, 2021
Annie Im, MD
Annie Im, MD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
- 1.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.00 Attendance